MCKESSON CORP

CEO Tyler S. sells 8,463 McKesson shares—routine rule‑144 trading. Investors learn the sale’s impact, company fundamentals, and future insider‑trading signals.

CEO Ty Brion sells 4,929 McKesson shares under a 10b5‑1 plan— a routine move amid Q2 gains that signals disciplined governance and steady growth confidence.

Rodgers Thomas L’s recent 123‑share sale at McKesson signals disciplined insider liquidity amid a $1.25 billion Apollo investment, yet the company’s resilient health‑care distribution strategy keeps investors confident for the long term.

Explore MCKESSON CORP’s insider sales: LeAnn Smith’s recent 1,810‑share sale, its impact on stock trends, and what it signals for investors.

McKesson insider buying: CFO Kenny Cheung’s recent RSU purchase signals leadership confidence, hinting at upside potential amid a dip to the 52‑week low.

McKesson insider trades: Michele’s 3,550‑share sale follows a rule‑based pattern that shows management confidence but little impact on the stock.

McKesson insider trading: EVP Fraga Francisco’s mixed buy‑sell‑RSU moves signal confidence amid rising social media buzz, hinting at upcoming strategic shifts.

McKesson insider sale: EVP Lau Michele sells 303 shares under 10b5‑1, hinting at routine liquidity but raising investor curiosity about future confidence.

McKesson insider trades reveal strategic confidence: LeAnn Smith’s buys and sells near a 52‑week high signal cautious optimism while investors watch for tech‑driven growth.

Insider sale by McKesson SVP highlights a 10b5‑1 plan during a bullish earnings run, showing portfolio rebalancing not a warning, yet the stock remains poised for upside.